Sarepta CEO Vows To Get Exondys 51 Into EU Despite CHMP Negative Trend Vote

 
• By Sten Stovall
DMD
Sarepta’s DMD Drug Eteplirsen Has Been Rebuffed By European Regulatory Advisors • Source: Shutterstock

More from New Products

More from Scrip